Open AccessAnti-CD20 monoclonal antibody in multiple sclerosis therapy: the results of phase 3 clinical studies on relapsing and primary progressive multiple sclerosis
Author(s) -
Maciej Maciejowski
Publication year - 2015
Publication title -
aktualności neurologiczne
Language(s) - English
Resource type - Journals
eISSN - 2451-0696
pISSN - 1641-9227
DOI - 10.15557/an.2015.0022
Subject(s) - medicine , multiple sclerosis , monoclonal antibody therapy , monoclonal antibody , ocrelizumab , cd20 , antibody , rituximab , monoclonal , oncology , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom